1. Home
  2. VATE vs NVNO Comparison

VATE vs NVNO Comparison

Compare VATE & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VATE
  • NVNO
  • Stock Information
  • Founded
  • VATE 1994
  • NVNO 1987
  • Country
  • VATE United States
  • NVNO United States
  • Employees
  • VATE N/A
  • NVNO N/A
  • Industry
  • VATE Metal Fabrications
  • NVNO Medical/Dental Instruments
  • Sector
  • VATE Industrials
  • NVNO Health Care
  • Exchange
  • VATE Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • VATE 70.3M
  • NVNO 71.0M
  • IPO Year
  • VATE 1996
  • NVNO N/A
  • Fundamental
  • Price
  • VATE $5.81
  • NVNO $4.96
  • Analyst Decision
  • VATE
  • NVNO
  • Analyst Count
  • VATE 0
  • NVNO 0
  • Target Price
  • VATE N/A
  • NVNO N/A
  • AVG Volume (30 Days)
  • VATE 16.3K
  • NVNO 137.7K
  • Earning Date
  • VATE 08-05-2025
  • NVNO 08-04-2025
  • Dividend Yield
  • VATE N/A
  • NVNO N/A
  • EPS Growth
  • VATE N/A
  • NVNO N/A
  • EPS
  • VATE N/A
  • NVNO N/A
  • Revenue
  • VATE $1,066,100,000.00
  • NVNO N/A
  • Revenue This Year
  • VATE N/A
  • NVNO N/A
  • Revenue Next Year
  • VATE N/A
  • NVNO N/A
  • P/E Ratio
  • VATE N/A
  • NVNO N/A
  • Revenue Growth
  • VATE N/A
  • NVNO N/A
  • 52 Week Low
  • VATE $3.25
  • NVNO $2.03
  • 52 Week High
  • VATE $13.79
  • NVNO $5.92
  • Technical
  • Relative Strength Index (RSI)
  • VATE 56.23
  • NVNO 62.60
  • Support Level
  • VATE $5.09
  • NVNO $4.72
  • Resistance Level
  • VATE $6.00
  • NVNO $5.13
  • Average True Range (ATR)
  • VATE 0.35
  • NVNO 0.38
  • MACD
  • VATE 0.06
  • NVNO 0.06
  • Stochastic Oscillator
  • VATE 79.12
  • NVNO 61.85

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: